AlphaCore Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
AlphaCore Capital's AMGN Position: Q3 2026 in Review
AlphaCore Capital increased its Amgen (AMGN) stake by 11% in Q3 2026, buying an estimated $569K and bringing the position to 14,567 shares worth $6.14M. The position accounts for 0.1% of the portfolio, ranked #174.
AlphaCore Capital first reported a position in AMGN in Q1 2020 and has held it in 12 quarters since. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- AlphaCore Capital held 14,567 shares of Amgen worth $6.14M as of Q3 2026.
- AlphaCore Capital bought 1,427 Amgen shares in Q3 2026, an estimated $569K.
- Amgen made up 0.1% of AlphaCore Capital's portfolio in Q3 2026, its #174 holding.
- AlphaCore Capital first reported a position in Amgen in Q1 2020 and has held it in 12 quarters since.
- 2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.